Full Text
The Full Text of this article is available as a PDF (84.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. doi: 10.1126/science.2136249. [DOI] [PubMed] [Google Scholar]
- Cheng A. M., Saxton T. M., Sakai R., Kulkarni S., Mbamalu G., Vogel W., Tortorice C. G., Cardiff R. D., Cross J. C., Muller W. J. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell. 1998 Dec 11;95(6):793–803. doi: 10.1016/s0092-8674(00)81702-x. [DOI] [PubMed] [Google Scholar]
- Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science. 1990 Aug 31;249(4972):1007–1011. doi: 10.1126/science.2204108. [DOI] [PubMed] [Google Scholar]
- Daly R. J., Binder M. D., Sutherland R. L. Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene. 1994 Sep;9(9):2723–2727. [PubMed] [Google Scholar]
- Edery P., Lyonnet S., Mulligan L. M., Pelet A., Dow E., Abel L., Holder S., Nihoul-Fékété C., Ponder B. A., Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):378–380. doi: 10.1038/367378a0. [DOI] [PubMed] [Google Scholar]
- Fearon E. R. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997 Nov 7;278(5340):1043–1050. doi: 10.1126/science.278.5340.1043. [DOI] [PubMed] [Google Scholar]
- Hansford J. R., Mulligan L. M. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000 Nov;37(11):817–827. doi: 10.1136/jmg.37.11.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hethcote H. W., Knudson A. G., Jr Model for the incidence of embryonal cancers: application to retinoblastoma. Proc Natl Acad Sci U S A. 1978 May;75(5):2453–2457. doi: 10.1073/pnas.75.5.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pasini B., Borrello M. G., Greco A., Bongarzone I., Luo Y., Mondellini P., Alberti L., Miranda C., Arighi E., Bocciardi R. Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet. 1995 May;10(1):35–40. doi: 10.1038/ng0595-35. [DOI] [PubMed] [Google Scholar]
- Pasini B., Ceccherini I., Romeo G. RET mutations in human disease. Trends Genet. 1996 Apr;12(4):138–144. doi: 10.1016/0168-9525(96)10012-3. [DOI] [PubMed] [Google Scholar]
- Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Käriäinen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):377–378. doi: 10.1038/367377a0. [DOI] [PubMed] [Google Scholar]
- Verbeek B. S., Adriaansen-Slot S. S., Rijksen G., Vroom T. M. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol. 1997 Oct;183(2):195–203. doi: 10.1002/(SICI)1096-9896(199710)183:2<195::AID-PATH901>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]